Department Publications 2004

  1. Adwanikar, H., F. Karim, et al. (2004). “Inflammation persistently enhances nocifensive behaviors mediated by spinal group I mGluRs through sustained ERK activation.” Pain 111(1-2): 125-35.
  2. Akata, T., T. Kanna, et al. (2004). “Reliability of fingertip skin-surface temperature and its related thermal measures as indices of peripheral perfusion in the clinical setting of the operating theatre.” Anaesth Intensive Care 32(4): 519-29.
  3. Akk, G., J. Bracamontes, et al. (2004). “Activation of GABA(A) receptors containing the alpha4 subunit by GABA and pentobarbital.” J Physiol 556(Pt 2): 387-99.
  4. Akk, G., J. R. Bracamontes, et al. (2004). “Neuroactive steroids have multiple actions to potentiate GABAA receptors.” J Physiol 558(Pt 1): 59-74.
  5. Altuntas, T. G., S. B. Park, et al. (2004). “Sulfoxidation of cysteine and mercapturic acid conjugates of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A).” Chem Res Toxicol 17(3): 435-45.
  6. Amar, D., W. Shi, et al. (2004). “Clinical prediction rule for atrial fibrillation after coronary artery bypass grafting.” J Am Coll Cardiol 44(6): 1248-53.
  7. Avidan, M. S., E. L. Alcock, et al. (2004). “Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery.” Br J Anaesth 92(2): 178-86.
  8. Azpiazu, I. and N. Gautam (2004). “A fluorescence resonance energy transfer-based sensor indicates that receptor access to a G protein is unrestricted in a living mammalian cell.” J Biol Chem 279(26): 27709-18.
  9. Bhave, G. and R. W. t. Gereau (2004). “Posttranslational mechanisms of peripheral sensitization.” J Neurobiol 61(1): 88-106.
  10. Bommhardt, U., K. C. Chang, et al. (2004). “Akt decreases lymphocyte apoptosis and improves survival in sepsis.” J Immunol 172(12): 7583-91.
  11. Braun, E. B., C. A. Palin, et al. (2004). “Vasopressin during spinal anesthesia in a patient with primary pulmonary hypertension treated with intravenous epoprostenol.” Anesth Analg 99(1): 36-7.
  12. Coopersmith, C. M., J. E. Zack, et al. (2004). “The impact of bedside behavior on catheter-related bacteremia in the intensive care unit.” Arch Surg 139(2): 131-6.
  13. Crowder, C. M. (2004). “Ethanol targets: a BK channel cocktail in C. elegans.” Trends Neurosci 27(10): 579-82.
  14. Dai, Y., K. Iwanaga, et al. (2004). “In vitro metabolism of cyclosporine A by human kidney CYP3A5.” Biochem Pharmacol 68(9): 1889-902.
  15. Dale, O., P. Sheffels, et al. (2004). “Bioavailabilities of rectal and oral methadone in healthy subjects.” Br J Clin Pharmacol 58(2): 156-62.
  16. Darbandi-Tonkabon, R., B. D. Manion, et al. (2004). “Neuroactive steroid interactions with voltage-dependent anion channels: lack of relationship to GABA(A) receptor modulation and anesthesia.” J Pharmacol Exp Ther 308(2): 502-11.
  17. De Wet, C. J., D. G. Affleck, et al. (2004). “Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery.” J Thorac Cardiovasc Surg 127(4): 1058-67.
  18. Ding, Y. Q., J. Yin, et al. (2004). “Lmx1b controls the differentiation and migration of the superficial dorsal horn neurons of the spinal cord.” Development 131(15): 3693-703.
  19. Efron, P. A., K. Tinsley, et al. (2004). “Increased lymphoid tissue apoptosis in baboons with bacteremic shock.” Shock 21(6): 566-71.
  20. Fatheree, R. S. and B. L. Leighton (2004). “Acute respiratory distress syndrome after an exothermic Baralyme-sevoflurane reaction.” Anesthesiology 101(2): 531-3.
  21. Hantler, C., G. J. Despotis, et al. (2004). “Guidelines and alternatives for neuraxial anesthesia and venous thromboembolism prophylaxis in major orthopedic surgery.” J Arthroplasty 19(8): 1004-16.
  22. Hashiguchi, K., T. Morioka, et al. (2004). “[Postoperative transient hemiplegia after resection of the medial frontal tumor involving the supplementary motor area: report of two cases].” No Shinkei Geka 32(9): 947-53.
  23. Hawasli, A. H., O. Saifee, et al. (2004). “Resistance to volatile anesthetics by mutations enhancing excitatory neurotransmitter release in Caenorhabditis elegans.” Genetics 168(2): 831-43.
  24. Hill, L. L., D. L. Chen, et al. (2004). “Neutrophils and neutrophil products do not mediate pulmonary hemodynamic effects of endotoxin on oleic acid-induced lung injury.” Anesth Analg 98(2): 452-7, table of contents.
  25. Hill, L. L., C. J. De Wet, et al. (2004). “Peripartum substitution of inhaled for intravenous prostacyclin in a patient with primary pulmonary hypertension.” Anesthesiology 100(6): 1603-5.
  26. Hiltebrand, L. B., V. Krejci, et al. (2004). “Effects of dopamine, dobutamine, and dopexamine on microcirculatory blood flow in the gastrointestinal tract during sepsis and anesthesia.” Anesthesiology 100(5): 1188-97.
  27. Hotchkiss, R. S. and I. E. Karl (2004). “Endothelial cell apoptosis in sepsis: a case of habeas corpus?” Crit Care Med 32(3): 901-2.
  28. Javadi, P., T. G. Buchman, et al. (2004). “High-dose exogenous iron following cecal ligation and puncture increases mortality rate in mice and is associated with an increase in gut epithelial and splenic apoptosis.” Crit Care Med 32(5): 1178-85.
  29. Kharasch, E. D. (2004). “Perioperative COX-2 inhibitors: knowledge and challenges.” Anesth Analg 98(1): 1-3.
  30. Kharasch, E. D., C. Hoffer, et al. (2004). “The effect of quinidine, used as a probe for the involvement of P-glycoprotein, on the intestinal absorption and pharmacodynamics of methadone.” Br J Clin Pharmacol 57(5): 600-10.
  31. Kharasch, E. D., C. Hoffer, et al. (2004). “Influence of age on the pharmacokinetics and pharmacodynamics of oral transmucosal fentanyl citrate.” Anesthesiology 101(3): 738-43.
  32. Kharasch, E. D., C. Hoffer, et al. (2004). “Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone.” Clin Pharmacol Ther 76(3): 250-69.
  33. Kharasch, E. D., A. Walker, et al. (2004). “Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis.” Clin Pharmacol Ther 76(5): 452-66.
  34. Kharasch, E. D., D. Whittington, et al. (2004). “Influence of hepatic and intestinal cytochrome P4503A activity on the acute disposition and effects of oral transmucosal fentanyl citrate.” Anesthesiology 101(3): 729-37.
  35. Leone, M., F. Garnier, et al. (2004). “Catheter-associated urinary tract infections in intensive care units.” Microbes Infect 6(11): 1026-32.
  36. Leone, M., S. Rousseau, et al. (2004). “Target concentrations of remifentanil with propofol to blunt coughing during intubation, cuff inflation, and tracheal suctioning.” Br J Anaesth 93(5): 660-3.
  37. Markovitz, B. P. (2004). “The wired pediatric intensive care unit today: what is your patient’s URL?” Pediatr Crit Care Med 5(5): 493-4.
  38. Mennerick, S., Y. He, et al. (2004). “Selective antagonism of 5alpha-reduced neurosteroid effects at GABA(A) receptors.” Mol Pharmacol 65(5): 1191-7.
  39. Morioka, T., K. Hashiguchi, et al. (2004). “[Surgical treatment for temporal lobe epilepsy in patients over age 50 years].” No To Shinkei 56(4): 326-32.
  40. Murray, D. J., J. R. Boulet, et al. (2004). “Acute care skills in anesthesia practice: a simulation-based resident performance assessment.” Anesthesiology 101(5): 1084-95.
  41. Nagele, P., M. Hupfl, et al. (2004). “Epidemiology and outcome of pediatric trauma treated by an emergency-physician-staffed advanced life-support unit.” Wien Klin Wochenschr 116(11-12): 398-403.
  42. Nagele, P., L. B. Metz, et al. (2004). “Nitrous oxide (N(2)O) requires the N-methyl-D-aspartate receptor for its action in Caenorhabditis elegans.” Proc Natl Acad Sci U S A 101(23): 8791-6.
  43. Ratnaraj, J., B. Kabon, et al. (2004). “Supplemental oxygen and carbon dioxide each increase subcutaneous and intestinal intramural oxygenation.” Anesth Analg 99(1): 207-11.
  44. Ren, X. R., G. L. Ming, et al. (2004). “Focal adhesion kinase in netrin-1 signaling.” Nat Neurosci 7(11): 1204-12.
  45. Rosemeier, F., J. B. Shumway, et al. (2004). “Successful pregnancy and cesarean delivery 22 years after separation in an ischiopagus tetrapus conjoined twin.” Anesthesiology 100(6): 1601-3.
  46. Saleh, M., J. P. Vaillancourt, et al. (2004). “Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms.” Nature 429(6987): 75-9.
  47. Sheffels, P., J. L. Schroeder, et al. (2004). “Role of cytochrome P4503A in cysteine S-conjugates sulfoxidation and the nephrotoxicity of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A) in rats.” Chem Res Toxicol 17(9): 1177-89.
  48. Taguchi, A., J. Ratnaraj, et al. (2004). “Effects of a circulating-water garment and forced-air warming on body heat content and core temperature.” Anesthesiology 100(5): 1058-64.
  49. Taylor, B. E., W. Y. Huey, et al. (2004). “Treatment of hypophosphatemia using a protocol based on patient weight and serum phosphorus level in a surgical intensive care unit.” J Am Coll Surg 198(2): 198-204.
  50. Tempelhoff, R. (2004). “Ischemic optic neuropathy: “whodunit?”” Can J Anaesth 51(4): 286-9.
  51. Turnbull, I. R., T. G. Buchman, et al. (2004). “Age disproportionately increases sepsis-induced apoptosis in the spleen and gut epithelium.” Shock 22(4): 364-8.
  52. Turnbull, I. R., P. Javadi, et al. (2004). “Antibiotics improve survival in sepsis independent of injury severity but do not change mortality in mice with markedly elevated interleukin 6 levels.” Shock 21(2): 121-5.
  53. Whittington, D., P. Sheffels, et al. (2004). “Stereoselective determination of methadone and the primary metabolite EDDP in human plasma by automated on-line extraction and liquid chromatography mass spectrometry.” J Chromatogr B Analyt Technol Biomed Life Sci 809(2): 313-21.
  54. Wizorek, J. J., C. M. Coopersmith, et al. (2004). “Sequence makes a difference: paradoxical effects of stress in vivo.” Shock 22(3): 229-33.
  55. Wu, X. S., J. Y. Sun, et al. (2004). “Isoflurane inhibits transmitter release and the presynaptic action potential.” Anesthesiology 100(3): 663-70.
  56. Xia, X. M., X. Zhang, et al. (2004). “Ligand-dependent activation of Slo family channels is defined by interchangeable cytosolic domains.” J Neurosci 24(24): 5585-91.
  57. Yang, D. and R. W. t. Gereau (2004). “Group II metabotropic glutamate receptors inhibit cAMP-dependent protein kinase-mediated enhancemednt of tetrodotoxin-resistant sodium currents in mouse dorsal root ganglion neurons.” Neurosci Lett 357(3): 159-62.